InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
16
T+90 hit rate
33%
T+90 mean return
-28.9%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Salter Malcolm, Director. Officer active across 1 company, notably C4 Therapeutics, Inc.. Cumulatively, 22 disclosures have been recorded. Split: 0 buy · 16 sells. Total volume traded: €410k. Activity tracked since 21 May 2021. The latest transaction was filed on 4 January 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations22 total
428 shares@ US$31.580.0065% mcap5.0% of flowCommon StockSEC:0001209191-22-003504
428 shares@ US$31.580.0065% mcap2.5% of flowCommon StockSEC:0001209191-22-003504:0
755 shares@ US$30.254.2% of flowCommon StockSEC:0001209191-21-070273
755 shares@ US$30.250.011% mcap4.2% of flowCommon StockSEC:0001209191-21-070273:0
755 shares@ US$40.115.6% of flowCommon StockSEC:0001209191-21-065820
755 shares@ US$40.110.014% mcap5.6% of flowCommon StockSEC:0001209191-21-065820:0
755 shares@ US$44.940.016% mcap6.1% of flowCommon StockSEC:0001209191-21-060568:0
755 shares@ US$44.946.1% of flowCommon StockSEC:0001209191-21-060568
300 shares@ US$44.990.0063% mcap2.4% of flowCommon StockSEC:0001209191-21-059530:0
300 shares@ US$44.992.4% of flowCommon StockSEC:0001209191-21-059530
755 shares@ US$49.890.017% mcap6.7% of flowCommon StockSEC:0001209191-21-057117:0
755 shares@ US$49.896.7% of flowCommon StockSEC:0001209191-21-057117
755 shares@ US$40.730.014% mcap5.5% of flowCommon StockSEC:0001209191-21-053162:0
755 shares@ US$40.735.5% of flowCommon StockSEC:0001209191-21-053162
755 shares@ US$37.375.0% of flowCommon StockSEC:0001209191-21-047169
755 shares@ US$37.370.013% mcap5.0% of flowCommon StockSEC:0001209191-21-047169:0
339 shares@ US$39.722.4% of flowCommon StockSEC:0001209191-21-045808
339 shares@ US$39.720.0061% mcap2.4% of flowCommon StockSEC:0001209191-21-045808:0
755 shares@ US$37.194.9% of flowCommon StockSEC:0001209191-21-042300
755 shares@ US$37.190.013% mcap4.9% of flowCommon StockSEC:0001209191-21-042300:0
755 shares@ US$37.124.8% of flowCommon StockSEC:0001209191-21-035501
755 shares@ US$37.120.012% mcap4.8% of flowCommon StockSEC:0001209191-21-035501:0
22 of 22 declarations
About Salter Malcolm
Malcolm Salter is an executive at C4 Therapeutics, Inc.
